These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 8725876)

  • 1. GAD antibodies in IDDM in Thailand.
    Rattarasarn C; Aguilar-Diosdado M; Soonthornpun S; Patarakijvanich N; Jaruratanasirikul S
    Diabetes Care; 1996 Jun; 19(6):674-5. PubMed ID: 8725876
    [No Abstract]   [Full Text] [Related]  

  • 2. Cellular immune response to GAD in type 1 diabetes with residual beta-cell function.
    Fukui M; Nakamura N; Nakano K; Kondo M
    Diabetes Care; 1999 Oct; 22(10):1758-9. PubMed ID: 10526760
    [No Abstract]   [Full Text] [Related]  

  • 3. Difference between islet cell antibodies and autoantibodies to glutamic acid decarboxylase-containing Purkinje cells in IDDM.
    Kobayashi T; Nakanishi K; Murase T; Kosaka K
    Diabetes Care; 1992 Oct; 15(10):1435-6. PubMed ID: 1425115
    [No Abstract]   [Full Text] [Related]  

  • 4. Antibodies to GAD in Japanese diabetic patients: a multicenter study.
    Tsuruoka A; Matsuba I; Toyota T; Isshiki G; Nagataki S; Ikeda Y
    Diabetes Res Clin Pract; 1995 Jun; 28(3):191-9. PubMed ID: 8529498
    [TBL] [Abstract][Full Text] [Related]  

  • 5. GAD antibodies seldom disappear in slowly progressive IDDM.
    Kobayashi T; Nakanishi K; Okubo M; Murase T; Kosaka K
    Diabetes Care; 1996 Sep; 19(9):1031. PubMed ID: 8875105
    [No Abstract]   [Full Text] [Related]  

  • 6. Relationship between GAD antibody and residual beta-cell function in children after overt onset of IDDM.
    Yokota I; Shirakawa N; Shima K; Matsuda J; Naito E; Ito M; Kuroda Y
    Diabetes Care; 1996 Jan; 19(1):74-5. PubMed ID: 8720540
    [No Abstract]   [Full Text] [Related]  

  • 7. Anti-GAD antibodies in Chinese patients with youth and adult-onset IDDM and NIDDM.
    Thai AC; Ng WY; Loke KY; Lee WR; Lui KF; Cheah JS
    Diabetologia; 1997 Dec; 40(12):1425-30. PubMed ID: 9447950
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Presence of anti-pituitary antibodies and GAD antibodies in NIDDM and IDDM.
    Kobayashi T; Yabe S; Kikuchi T; Kanda T; Kobayashi I
    Diabetes Care; 1997 May; 20(5):864-6. PubMed ID: 9135957
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Anti-GAD-positive patients with type 1 diabetes mellitus have higher prevalence of autoimmune thyroiditis than anti-GAD-negative patients with type 1 and type 2 diabetes mellitus.
    Bárová H; Perusicová J; Hill M; Sterzl I; Vondra K; Masek Z
    Physiol Res; 2004; 53(3):279-86. PubMed ID: 15209535
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Autoantibodies to glutamic acid decarboxylase in patients with IDDM and autoimmune thyroid disease.
    Kawasaki E; Takino H; Yano M; Uotani S; Matsumoto K; Takao Y; Yamaguchi Y; Akazawa S; Nagataki S
    Diabetes; 1994 Jan; 43(1):80-6. PubMed ID: 8262321
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Persisting antibodies to glutamic acid decarboxylase in type 1 (insulin-dependent) diabetes mellitus are not associated with neuropathy.
    Tuomi T; Zimmet PZ; Rowley MJ; Serjeantson SW; Mackay IR
    Diabetologia; 1993 Jul; 36(7):685. PubMed ID: 8359590
    [No Abstract]   [Full Text] [Related]  

  • 12. Antibodies to GAD in elderly patients with previously diagnosed NIDDM.
    Fukui M; Nakamura N; Nakano K; Sawada M; Aoji O; Obayashi H; Shigeta H; Kondo M
    Diabetes Care; 1998 Apr; 21(4):675-6. PubMed ID: 9571369
    [No Abstract]   [Full Text] [Related]  

  • 13. Gender differences in GAD antibody-positive diabetes mellitus in relation to age at onset, C-peptide and other endocrine autoimmune diseases.
    Lindholm E; Hallengren B; Agardh CD
    Diabetes Metab Res Rev; 2004; 20(2):158-64. PubMed ID: 15037992
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Do GAD antibodies at IDDM onset predict the clinical course of diabetes in children?
    Kordonouri O; Danne T; Weber B
    Diabetes Care; 1996 Aug; 19(8):901-2. PubMed ID: 8842617
    [No Abstract]   [Full Text] [Related]  

  • 15. Prevalence of antibodies to glutamic acid decarboxylase in women who have had gestational diabetes.
    Beischer NA; Wein P; Sheedy MT; Mackay IR; Rowley MJ; Zimmet P
    Am J Obstet Gynecol; 1995 Nov; 173(5):1563-9. PubMed ID: 7503202
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Autoantibodies associated with presymptomatic insulin-dependent diabetes mellitus in women.
    Whittingham S; Byron SL; Tuomilehto J; Zimmet PZ; Myers MA; Vidgren G; Rowley MJ; Feeney SJ; Koskela P; Tuomilehto-Wolf E; Mackay IR
    Diabet Med; 1997 Aug; 14(8):678-85. PubMed ID: 9272595
    [TBL] [Abstract][Full Text] [Related]  

  • 17. High prevalence of GAD65 (and IA-2) antibodies in Japanese IDDM patients by a new immunoprecipitation assay based on recombinant human GAD65.
    Akamine H; Komiya I; Shimabukuro T; Asawa T; Tanaka H; Yagi N; Taira T; Nagata K; Arakaki K; Wakugami T; Takasu N; Powell MJ; Furmaniak J; Smith BR
    Diabet Med; 1997 Sep; 14(9):778-84. PubMed ID: 9300229
    [TBL] [Abstract][Full Text] [Related]  

  • 18. GAD antibody in multiplex diabetic pedigrees of Chinese.
    Chen T; Ren Y; Long Y; Zhang X; Yu H; Tian H
    Diabetes Care; 2007 Dec; 30(12):3091-2. PubMed ID: 17878243
    [No Abstract]   [Full Text] [Related]  

  • 19. Pancreatic islet cell cytoplasmic antibody in diabetes is represented by antibodies to islet cell antigen 512 and glutamic acid decarboxylase.
    Myers MA; Rabin DU; Rowley MJ
    Diabetes; 1995 Nov; 44(11):1290-5. PubMed ID: 7589826
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Combined measurements of GAD65 and ICA512 antibodies in acute onset and slowly progressive IDDM.
    Yamada K; Yuan X; Inada C; Hayashi H; Koyama K; Ichikawa F; Eisenbarth GS; Nonaka K
    Diabetes Res Clin Pract; 1997 Mar; 35(2-3):91-8. PubMed ID: 9179463
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.